First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics

We evaluated the potential of cardiovascular-disease-associated microRNAs for early prediction of HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Gene expression profiling of 29 microRNAs was performed on whole peripheral venous blood samples collected between 10 and 13 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Hromadnikova, Ilona, Kotlabova, Katerina, Krofta, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049724/
https://www.ncbi.nlm.nih.gov/pubmed/36982251
http://dx.doi.org/10.3390/ijms24065177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049724/
https://www.ncbi.nlm.nih.gov/pubmed/36982251
http://dx.doi.org/10.3390/ijms24065177

Ejemplares similares